In last trading session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) saw 0.76 million shares changing hands with its beta currently measuring 0.05. Company’s recent per share price level of $1.11 trading at $0.07 or 6.73% at ring of the bell on the day assigns it a market valuation of $51.70M. That closing price of RVPH’s stock is at a discount of -285.59% from its 52-week high price of $4.28 and is indicating a premium of 45.95% from its 52-week low price of $0.60. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.8 million shares which gives us an average trading volume of 2.42 million if we extend that period to 3-months.
For Reviva Pharmaceuticals Holdings Inc (RVPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.22 in the current quarter.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Upright in the green during last session for gaining 6.73%, in the last five days RVPH remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $1.11 price level, adding 9.39% to its value on the day. Reviva Pharmaceuticals Holdings Inc’s shares saw a change of -38.67% in year-to-date performance and have moved -3.48% in past 5-day. Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) showed a performance of -40.64% in past 30-days. Number of shares sold short was 3.79 million shares which calculate 2.72 days to cover the short interests.
In 2025, company’s earnings growth rate is likely to be around 40.26% while estimates for its earnings growth in next 5 years are of 20.47%.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Insiders are in possession of 14.30% of company’s total shares while institution are holding 29.49 percent of that, with stock having share float percentage of 34.41%. Investors also watch the number of corporate investors in a company very closely, which is 29.49% institutions for Reviva Pharmaceuticals Holdings Inc that are currently holding shares of the company. WOODLINE PARTNERS LP is the top institutional holder at RVPH for having 1.59 million shares of worth $2.04 million. And as of 2024-06-30, it was holding 5.2129 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.03 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.2659 of outstanding shares, having a total worth of $1.31 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 930.44 shares of worth $1.03 million or 2.78% of the total outstanding shares. The later fund manager was in possession of 312.3 shares on Dec 31, 2024 , making its stake of worth around $0.35 million in the company or a holder of 0.93% of company’s stock.
